drugset / Trial / NCT01980472
Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients
NaSingle-groupOpen-labelOther
Summary
A phase II Study of an adapted chemotherapy regimen plus bevacizumab in elderly non-small cell lung cancer patients selected by geriatric assessment
Timeline
- Start
- 2013-08
- Primary completion
- 2015-06
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | — |
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |